Industry Updates
Press Releases
SonoSite supports first pan-European ESRA training
Saturday the 27th of January 2018 marks the first ESRA European Day of Regional Anaesthesia, delivered simultaneously in over 20 training hubs across the continent.
FUJIFILM...
Press Releases
Nuance Unveils AI-Powered Dragon Medical Practice Edition 4
Nuance Communications, Inc. announced the release of Dragon Medical Practice Edition 4, the latest locally installed version of Nuance’s industry-leading clinical speech recognition solution for...
Industry Updates
Charles River Laboratories Acquires KWS BioTest
Charles River Laboratories International, Inc. announced that it has acquired KWS BioTest, a leading contract research organization (CRO) specializing in in vitro and in vivo...
Press Releases
Check-Cap Receives CE Mark Approval for C-Scan®
Check-Cap Ltd. a clinical-stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule for preparation-free, colorectal cancer screening, announced it has received...
Press Releases
FDA Approves XGEVA for the prevention of Skeletal-Related Events in patients with multiple myeloma
Amgen announced that the US FDA has approved the supplemental Biologics License Application (sBLA) for Xgeva (denosumab) to expand the currently approved indication for the...
Press Releases
Abbott’s CGM system, FreeStyle Libre System now available to Medicare patients
Abbott has announced that the FreeStyle Libre System, the company's revolutionary new continuous glucose monitoring (CGM) system, is now available to Medicare patients, having met...
Press Releases
AvantGen to use its proprietary human antibody yeast display platform to generate additional novel cancer therapeutic antibody drug candidates for Tanabe Research Laboratories USA
AvantGen announced the successful completion of a first cancer therapeutic antibody discovery program for Tanabe Research Laboratories USA, Inc. (TRL) and the initiation of a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.

















